The role and therapeutic potential of prohibitin in disease
- 30 June 2011
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1813 (6), 1137-1143
- https://doi.org/10.1016/j.bbamcr.2011.01.033
Abstract
No abstract availableFunding Information
- The Broad Foundation (IBD-0226R)
- National Institutes of Health (R01-DK06411, K01-DK085222)
This publication has 93 references indexed in Scilit:
- Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitisInflammatory Bowel Diseases, 2011
- Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in miceHepatology, 2010
- Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2010
- Prohibitin Inhibits Tumor Necrosis Factor alpha–induced Nuclear Factor-kappa B Nuclear Translocation via the Novel Mechanism of Decreasing Importin α3 ExpressionMolecular Biology of the Cell, 2009
- Prohibitin Is a Novel Regulator of Antioxidant Response That Attenuates Colonic Inflammation in MiceGastroenterology, 2009
- Prohibitin protects against oxidative stress-induced cell injury in cultured neonatal cardiomyocyteCell Stress and Chaperones, 2008
- Prohibitin: a potential biomarker for tissue-based detection of gastric cancerThe Esophagus, 2008
- Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosisInternational Journal of Cancer, 2008
- Intestinal oxidative damage in inflammatory bowel disease: semi‐quantification, localization, and association with mucosal antioxidantsThe Journal of Pathology, 2003
- Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteinsThe EMBO Journal, 2000